WithdrawnPhase 2Other
Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)
Sponsored by Emergency NGO Onlus
NCT ID
NCT02307591
Start Date
2014-12
Est. Completion
2015-07
About This Study
The purpose of this study is to evaluate the efficacy and safety of amiodarone in the treatment of patients afflicted with Ebola virus disease.
Conditions Studied
Interventions
- •Best Supportive Care
- •Best Supportive Care + Amiodarone
Eligibility
Age:2 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * patient admitted to the Emergency ETC at Goderich with a clinical diagnosis of Ebola virus disease; * patient who consent to participate in the study. Exclusion Criteria: * negative RT-PCR tests for Ebola virus * age \<2 years * state of shock upon admission * onset of fever for more than 6 days * Glasgow Coma Scale \<12 * known contraindications to administration of amiodarone * positive for HIV antibodies.